Preliminary
Clinical Translation — Clinical trials, drug repurposing, regulatory pathways, and geroprotectors in humans
Review / Commentary
PubMed
This explains why hearts age and lists drugs and approaches that might slow that aging—a roadmap for preventing heart disease in older adults.
Provides integrative multi-scale framework of cardiovascular aging hallmarks and maps actionable therapeutic targets (senolytics, NAD+ pathway, anti-inflammatory, autonomic modulation) with current FDA approvals and trial landscape.
This comprehensive review identifies 12 hallmarks of how the heart and blood vessels age at molecular, cellular, and systemic levels—from DNA damage to inflammation to stem cell exhaustion. The authors map out current FDA-approved drugs …
Signal transduction and targeted therapy